Home  >  News
Msc_Jun22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  FoCus phase III trial of ALXN1840 shows rapid and sustained improvement in copper mobilisation from tissues, potentially closing treatment gaps for Wilson disease community,   June 25, 2022
  Sanofi-GSK first to report a successful efficacy study against Omicron with Covid-19 Beta-containing vaccine,   June 25, 2022
  Ahammune Biosciences, Veeda Clinical Research partner to initiate first in human studies with AB1001 to treat vitiligo,   June 24, 2022
  Biolexis and Akston Biosciences see positive results from phase II/III trial of thermostable 2nd Gen Covid-19 vaccine,   June 24, 2022
  InnoCare begins patient dosing in clinical trial of novel SHP2 allosteric inhibitor ICP-189 in China,   June 23, 2022
  Galderma’s phase III OLYMPIA 2 trial of nemolizumab in patients with prurigo nodularis meets primary & secondary endpoints,   June 23, 2022
  AlzeCure Pharma begins patient dosing in phase II trial in neuropathic pain with non-opioid ACD440,   June 22, 2022
  Immuneel Therapeutics announces India’s first phase II patient trials for CAR-T cancer therapies,   June 22, 2022
  Ionis announces phase 3 NEURO-TTRansform study of eplontersen in patients with ATTRv-PN meets co-primary and secondary endpoints,   June 22, 2022
  Merck presents positive results from phase 1/2 study of pneumococcal conjugate vaccine, V116 at ISPPD-12,   June 22, 2022
  Ocugen announces publication of positive paediatric phase 2/3 study results in children aged 2–18 years for Covid-19 vaccine, Covaxin in the Lancet,   June 22, 2022
  Acepodia receives US FDA clearance to initiate phase 1 study of ACE1831 in patients with non-Hodgkin's lymphoma,   June 21, 2022
  SoniVie gets IDE approval from US FDA for REDUCED1 Pilot study to treat hypertension with renal artery denervation TIVUS technology,   June 21, 2022
  Conformal Medical begins patient enrolment in CONFORM trial to evaluate safety and efficacy of CLAAS System compared to LAAO devices,   June 20, 2022
  Galecto begins patient enrollment in phase 2 trial of GB1211 in combo with atezolizumab to treat NSCLC,   June 18, 2022
  Addex terminates phase 2b/3 study of dipraglurant in patients with dyskinesia associated with Parkinson’s disease due to slow recruitment rate,   June 18, 2022
  Emmes supports AIDS Malignancy Consortium study,   June 18, 2022
  Vicore Pharma initiates first human trial with novel ATRAG, C106,   June 17, 2022
  Roche’s Alzheimer’s Prevention Initiative study of crenezumab in autosomal dominant Alzheimer’s disease fails to meet co-primary endpoints,   June 17, 2022
  ANCHOR study shows people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half,   June 17, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |